US$ 28.75
glp 1 or glp 2 GIP, GLP-1, GLP-2, and bone Effects of glucagon-like peptide 2
Description
You are trading FDA approval for a lower price

Our recent survey looked at the responses of real patients and analyzed the outcomes

In contrast, companies like Bayer, Sanofi, GSK, Otsuka, and Takeda are falling short of their peers in terms of total value, which is perhaps due to a weaker presence in high-value areas like oncology and neuroscience

American College of Gastroenterology - Patients

We summarize here the similarities and differences of these two incretin hormones in secretion and metabolism, their insulinotropic action on pancreatic cells, and their noninsulinotropic effects, and discuss their potential in treatment of type 2 diabetes
